Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2007-05-22 18:56:27 UTC |
---|
Update Date | 2023-02-21 17:17:16 UTC |
---|
HMDB ID | HMDB0006240 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Demethylated antipyrine |
---|
Description | Demethylated antipyrine is a novel potent free radical scavenger that has been clinically used to reduce the neuronal damage following ischemic stroke. Demethylated antipyrine exerts neuroprotective effects by inhibiting endothelial injury and by ameliorating neuronal damage in brain ischemia. Demethylated antipyrine provides the desirable features of NOS: it increases eNOS (beneficial NOS for rescuing ischemic stroke) and decreases nNOS and iNOS (detrimental NOS). Post- reperfusion brain edema and hemorrhagic events induced by thrombolytic therapy may be reduced by demethylated antipyrine pretreatment. Increased productions of superoxide and NO in the brain after reperfusion and a concomitant surge in oxygen free radicals with increased NO during recirculation lead to formation of peroxynitrite, a super potent radical. Demethylated antipyrine, which inhibits oxidation and enhances NO production derived from increased eNOS expression, may improve and conserve cerebral blood flow without peroxynitrite generation during reperfusion. Clinical experience with demethylated antipyrine suggests that this drug has a wide therapeutic time window. Demethylated antipyrine can exert a wide range of inhibitory effects on water-soluble and lipid soluble peroxyl radical-induced peroxidation systems, and appears to display combined properties of both, vitamin C and E. Demethylated antipyrine can scavenge not only hydroxyl radicals but also other free radicals, although it has no major effect on superoxide anion radicals. Demethylated antipyrine apparently traps hydroxyl radicals and inhibits OH-dependent lipid peroxidation or tyrosine nitration induced by peroxynitrite (ONOO-). Lipid peroxidation starts with lipid radical (L) production after free radical-mediated extraction of proton from unsaturated fatty acid. Subsequently lipid peroxyl radical (LOO) is generated by addition of oxygen atom, and a further L is produced by LOO-mediated extraction of proton from another unsaturated fatty acid. Demethylated antipyrine can inhibit lipid peroxidation by scavenging not only hydroxyl radicals but also other free radicals including LOO. Under physiological conditions, 50% of demethylated antipyrine is present as an anion form, and electrons released from demethylated antipyrine anion exert radical scavenging. Subsequently, demethylated antipyrine radicals are generated. They react readily with oxygen atoms, and form peroxyl radical of demethylated antipyrine, and eventually 2-oxo-3-(phenylhydrazone)- butanoic acid (OPB). (PMID: 16834755 , CNS Drug Rev. 2006 Spring;12(1):9-20.). |
---|
Structure | CC1=CC(=O)N(N1)C1=CC=CC=C1 InChI=1S/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-7,11H,1H3 |
---|
Synonyms | Value | Source |
---|
1-Phenyl-3-methyl-1H-4,5-dihydropyrazol-5-one | HMDB | 1-Phenyl-3-methyl-2-pyrazolin-5-one | HMDB | 1-Phenyl-3-methyl-5-oxopyrazole | HMDB | 1-Phenyl-3-methyl-5-pyrazolinone | HMDB | 1-Phenyl-3-methyl-5-pyrazolone | HMDB | 2,4-dihydro-5-Methyl-2-phenyl-3H-pyrazol-3-one | HMDB | 3-Methyl-1-phenyl-1H-pyrazol-5-one | HMDB | 3-Methyl-1-phenyl-2-pyrazolin-5-one | HMDB | 3-Methyl-1-phenyl-2-pyrazoline-5-one | HMDB | 3-Methyl-1-phenyl-4,5-dihydropyrazol-5-one | HMDB | 3-Methyl-1-phenyl-4,5-dihydropyrazole-5-one | HMDB | 3-Methyl-1-phenyl-5-pyrazolone | HMDB | 3-Methyl-1-phenylpyrazol-5(4H)-one | HMDB | 3-Methyl-1-phenylpyrazolin-5-one | HMDB | 5-Methyl-2-phenyl-2H-pyrazol-3(4H)-one | HMDB | 5-Methyl-2-phenylpyrazol-3-one | HMDB | Edarabone | HMDB | Edaravone | HMDB | Methylphenylpyrazolone | HMDB | Norantipyrine | HMDB | Norphenazone | HMDB | N-Demethylantipyrine, 14C-labeled | MeSH, HMDB | N-Demethylantipyrine | MeSH, HMDB |
|
---|
Chemical Formula | C10H10N2O |
---|
Average Molecular Weight | 174.1992 |
---|
Monoisotopic Molecular Weight | 174.079312952 |
---|
IUPAC Name | 5-methyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-one |
---|
Traditional Name | 5-methyl-2-phenyl-1H-pyrazol-3-one |
---|
CAS Registry Number | 89-25-8 |
---|
SMILES | CC1=CC(=O)N(N1)C1=CC=CC=C1 |
---|
InChI Identifier | InChI=1S/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-7,11H,1H3 |
---|
InChI Key | KZQYIMCESJLPQH-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenylpyrazoles. Phenylpyrazoles are compounds containing a phenylpyrazole skeleton, which consists of a pyrazole bound to a phenyl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Azoles |
---|
Sub Class | Pyrazoles |
---|
Direct Parent | Phenylpyrazoles |
---|
Alternative Parents | |
---|
Substituents | - Phenylpyrazole
- Monocyclic benzene moiety
- Pyrazolinone
- Benzenoid
- Heteroaromatic compound
- Vinylogous amide
- Lactam
- Azacycle
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | |
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Demethylated antipyrine,1TMS,isomer #1 | CC1=CC(=O)N(C2=CC=CC=C2)N1[Si](C)(C)C | 1687.8 | Semi standard non polar | 33892256 | Demethylated antipyrine,1TMS,isomer #1 | CC1=CC(=O)N(C2=CC=CC=C2)N1[Si](C)(C)C | 1820.6 | Standard non polar | 33892256 | Demethylated antipyrine,1TMS,isomer #1 | CC1=CC(=O)N(C2=CC=CC=C2)N1[Si](C)(C)C | 2159.1 | Standard polar | 33892256 | Demethylated antipyrine,1TBDMS,isomer #1 | CC1=CC(=O)N(C2=CC=CC=C2)N1[Si](C)(C)C(C)(C)C | 1923.0 | Semi standard non polar | 33892256 | Demethylated antipyrine,1TBDMS,isomer #1 | CC1=CC(=O)N(C2=CC=CC=C2)N1[Si](C)(C)C(C)(C)C | 2031.1 | Standard non polar | 33892256 | Demethylated antipyrine,1TBDMS,isomer #1 | CC1=CC(=O)N(C2=CC=CC=C2)N1[Si](C)(C)C(C)(C)C | 2241.2 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Demethylated antipyrine GC-MS (Non-derivatized) - 70eV, Positive | splash10-00di-4900000000-e7fde844e072d094e7bf | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Demethylated antipyrine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Demethylated antipyrine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethylated antipyrine 10V, Positive-QTOF | splash10-004i-0900000000-ccca975ba1e597027ed5 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethylated antipyrine 20V, Positive-QTOF | splash10-004i-0900000000-96da0ec122d8a8403486 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethylated antipyrine 40V, Positive-QTOF | splash10-0a4r-9500000000-905aac7834f5ebcbec59 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethylated antipyrine 10V, Negative-QTOF | splash10-00di-0900000000-8e7cd9ae2599cec8be88 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethylated antipyrine 20V, Negative-QTOF | splash10-00di-0900000000-dbe1b04ba8ec0bb7b01a | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethylated antipyrine 40V, Negative-QTOF | splash10-054k-6900000000-e3078766e74d43ea5dce | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethylated antipyrine 10V, Positive-QTOF | splash10-004i-0900000000-99e013a33d61f5b2babb | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethylated antipyrine 20V, Positive-QTOF | splash10-004i-0900000000-96887c840d6d9faeba92 | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethylated antipyrine 40V, Positive-QTOF | splash10-004i-9100000000-a5215b963ef8a7e94117 | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethylated antipyrine 10V, Negative-QTOF | splash10-00di-0900000000-6c988551b42e630dedc7 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethylated antipyrine 20V, Negative-QTOF | splash10-00xr-9600000000-0d26a32aab574f87a282 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Demethylated antipyrine 40V, Negative-QTOF | splash10-00kf-9100000000-89d891f53ac7bcc51cdb | 2021-09-25 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|